It is warned of the side effects of the trendy “health aid” for cannabis, as 56 are ill with “adverse drug effects”.
- The drug and health products regulator warned of an increase
- “Adverse drug reactions” were particularly pronounced among the 50 to 59 year olds
- Cannabidoil is ingested by up to seven million people, drawn to claims that it helps
- The Food Standards Agency urged pregnant and breastfeeding women not to ingest it
The number of people suffering from harmful side effects of lifestyle treatment cannabidiol – an active ingredient in cannabis – rose from four in 2017 to 56 last year.
The Regulatory Authority for Medicines and Health Products warned that the increase in “adverse drug reactions” among 50 to 59-year-olds aged 28 since 2007 has been particularly pronounced.
Cannabidiol, or CBD, is used by up to seven million people, drawn to claims that it helps with skin conditions, depression, and insomnia, among other things.
The regulatory authority for drugs and health products warned that the increase in “adverse drug effects” among 50 to 59 year olds at 28 has been particularly pronounced since 2007 (file).
The £ 300 million industry is projected to be worth £ 1 billion by 2025.
However, the Food Standards Agency (FSA) has advised pregnant and breastfeeding women not to take them.
Possible side effects include diarrhea, drooling, and damaged immune and reproductive systems. In April, a 56-year-old US woman became the first person to die from it.
Cannabidiol, or CBD, is ingested by up to seven million people drawn to claims that it helps with skin conditions, depression, and insomnia, among other things.
CBD is a “novel food” and manufacturers must prove their safety before selling. But the FSA has given existing companies until March 31st to obtain a novel food license.
Tory MP Craig Mackinlay said the industry is “a wild west”.